← stocks-llm Find companies like INGN →

INOGEN INC (INGN)

Health Care · Home respiratory care / portable oxygen therapy · NASDAQ

Inogen is a medical technology company developing portable oxygen concentrators and respiratory devices to improve mobility and quality of life for patients with chronic lung diseases like COPD.

What INOGEN INC does

Inogen develops, manufactures, and markets portable oxygen concentrators (POCs) and airway clearance devices for patients with chronic respiratory conditions such as COPD. The company's flagship Inogen One and Inogen Rove POC systems deliver supplemental long-term oxygen therapy while enabling patient mobility. Inogen also distributes the Simeox airway clearance device, and has recently begun marketing stationary oxygen concentrators (Voxi 5) and CPAP masks through a distribution collaboration with Yuwell.

Themes: ["Respiratory health / COPD","Portable medical devices","Oxygen therapy","Airway clearance","Chronic disease management","Sleep apnea treatment"]

Fundamentals

Ask why INGN looks like this →

Key risks (from latest filing)

["Company is currently unprofitable with net margin of -7.08% and has posted net losses in recent periods (Q1 2026: $8.3M loss); success depends on improving operational efficiency and achieving profitability","Significant warranty reserve obligations ($28.4M combined current and noncurrent as of Q1 2026) and deferred revenue liabilities indicate product warranty risks and potential customer satisfaction challenges","Heavy reliance on reimbursement from Medicare, Medicaid, and private insurers for POC sales; changes in reimbursement rates or coverage policies could materially impact revenue and market demand"]

See INGN's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.